BioSpace News Archive

KalVista Pharmaceuticals, Inc. announced the initiation of the KONFIDENT-S open label extension study for its ongoing Phase 3 KONFIDENT study of sebetralstat for the on-demand treatment of hereditary angioedema attacks.

Plus Therapeutics, Inc. today announced it will present data from the Phase 1/2a ReSPECT-GBM™ dose escalation clinical trial evaluating the Company’s lead investigational targeted radiotherapeutic, Rhenium-186 NanoLiposome ( 186 RNL).

Miromatrix Medical Inc. today announced that the company will participate in the Gilmartin Emerging Growth Company Showcase on August 31st, 2022.

Medivir AB announces that the company will present at the Erik Penser Bank Company Day on August 24, 2022.

From 300,000 mouse neurons, scientists hope to glean how the brain drives behavior. A newly released publicly available dataset is the largest of its kind and represents billions of split-second electrical pulses that comprise the brain’s language of information.

Braintale, a medtech deciphering white matter, spin off from the Paris Greater Hospitals has been awarded by the scientific committee of the 34th Eastern NeuroRadiology Society, whose annual meeting was held in Burlington on August 19th – 21st, 2022, the Robert D. Zimmerman Scientific Award for its communication.

Oculis S.A. announces that the results of the double blinded, multicenter and placebo controlled Phase 2 clinical trial assessing the effect of topical licaminlimab on global ocular discomfort in patients with severe dry eye disease has been published by the Clinical Ophthalmology journal.

CB Scientific. Inc. is pleased to announce that it has entered into a cooperative manufacturing agreement with Shenzhen Pump Medical Co., Ltd., a privately held, well-established medical device manufacturer, developer and distributor of cardiovascular medical equipment and devices based in Shenzhen, Nanshan, China.

Medtronic plc announced financial results for its first quarter of fiscal year 2023, which ended July 29, 2022.

Anavex Life Sciences Corp. today reported a relevant new peer-reviewed publication in the journal Science Translational Medicine, titled “Widespread cell stress and mitochondrial dysfunction occur in patients with early Alzheimer’s disease.”